Barrington Research Downgrades Hologic (HOLX) to Market Perform

August 5, 2014 10:31 AM EDT Send to a Friend
Get Alerts HOLX Hot Sheet
Price: $26.80 +1.21%

Rating Summary:
    9 Buy, 17 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 3 | Down: 17 | New: 2
Trade HOLX Now!
Join SI Premium – FREE

Barrington Research downgraded Hologic (NASDAQ: HOLX) from Outperform to Market Perform.

Analyst Charley R. Jones said, "We are downgrading HOLX to a MARKET PERFORM rating from an OUTPERFORM rating as we would prefer to wait for a better risk/reward. We certainly recognize that the transformation to 3-D is just beginning. We are finally going to get some service growth in the breast health division, which has struggled during the transition to 3-D as a result of the one-year lag on service due to the first year being free as part of a manufacturer warranty. We are also aware that NovaSure has already gone through a meaningful step down in revenue, but the fact is that there are headwinds in each of HOLX’s other segments and at nearly 20x and a 40% debt to cap, we’d rather wait."

For an analyst ratings summary and ratings history on Hologic click here. For more ratings news on Hologic click here.

Shares of Hologic closed at $25.86 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS View, Downgrades

Add Your Comment